Data Bridge Market Research recently added “
Global Non- Invasive Prenatal Testing Market by manufacturers, regions, type and application, forecast to 2028” in his database. This research report focus on complete assessment of market and contains future trend, growth factors, attentive opinions, facts, historical data, statistically supported and industry-validated market data. Environmental concerns & regulatory guidelines regarding release of effluents through different industries.
Global Non- Invasive Prenatal Testing Market comprehensive coverage of underlying economic and technological factors under key trend analysis.
Non-invasive prenatal testing market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 11.26 billion by 2027 growing at a CAGR of 15.57% in the above-mentioned forecast period. Rising healthcare expenditure worldwide is expected to create new opportunity for the marke
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global non-invasive prenatal testing market is currently witnessing strong growth. Non-invasive prenatal testing (NIPT) is a form of prenatal screening conducted on a pregnant woman s blood sample to detect the presence of fetal abnormalities. The test is primarily used to diagnose genetic disorders such as Down syndrome (or trisomy 21), Edwards syndrome (or trisomy 18), Patau syndrome (or trisomy 13) and Turner syndrome, by analyzing DNA fragments in the mother s blood. The procedure eliminates the need for various precarious and invasive procedures, such as chorionic villus sampling (CVS) and can be performed after nine weeks of pregnancy.